Wei Shifeng: process sterility assurance for injection re evaluation

From June 29, 2018 to June 30, 2018, under the guidance of China Pharmaceutical University, Chongqing Municipal Economic and Information Commission, sponsored by pharma.com and China Pharmacy magazine, and organized by Chongqing Kangzhou pharmaceutical big data development and Application Research Institute, Pharma elite club and pharma college, the third China Pharmaceutical R & D · innovation summit and 2018 top 100 list of China's pharmaceutical R & D strength will be released in Chongqing Marriott Hotel held a grand ceremony Dr Wei Shifeng will attend and deliver a keynote speech: Guest Speaker: Dr Wei Shifeng, co founder and general manager of Beijing luonuqiangshi pharmaceutical technology R & D Center Co., Ltd is committed to pharmaceutical preparation technical services and pharmaceutical preparation product development Dr Wei has rich working experience in international pharmaceutical companies and specializes in the development of pharmaceutical products He has successively worked in Roche pharmaceutical company (as a senior researcher), Johnson & Johnson pharmaceutical company (as a director researcher), member of Novartis pharmaceutical company (as a senior academician), Nick & Mead pharmaceutical company (as a technical director), and ruiwujian pharmaceutical company (as a vice president) in charge of product development Dr Wei has been engaged in injection, biological preparation and oral preparation for more than 20 years, Dr Wei also has experience in fdaid / NDA application, patent application, product technology transfer, etc Dr Wei Shifeng received his bachelor's degree from the school of pharmacy of Peking University (formerly Beijing Medical University) and his doctor's degree from the University of Minnesota Dr Wei was president of the American Association for the development of traditional Chinese medicine (SAPA, 1996-97) Dr Wei was elected to Beijing Haiju project Speech title: injection re evaluation process - sterility assurance For more details, please click [heavyweight] "the third China Pharmaceutical R & D Innovation Summit and 2018 China's top 100 pharmaceutical R & D strength list" will be held soon!